Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
107.00
+0.38 (0.36%)
Jul 1, 2026, 4:00 PM EDT - Market closed

Insmed Revenue

Insmed had revenue of $305.96M in the quarter ending March 31, 2026, with 229.62% growth. This brings the company's revenue in the last twelve months to $819.56M, up 115.09% year-over-year. In the year 2025, Insmed had annual revenue of $606.42M with 66.73% growth.

Revenue (ttm)
$819.56M
Revenue Growth
+115.09%
P/S Ratio
28.30
Revenue / Employee
$492,526
Employees
1,664
Market Cap
23.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.42M242.72M66.73%
Dec 31, 2024363.71M58.50M19.17%
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 201311.50M--
Dec 31, 2012---
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.70B
Incyte5.36B
Jazz Pharmaceuticals4.44B
Genmab3.90B
BioNTech SE3.23B
Royalty Pharma2.44B
Exelixis2.38B
Moderna2.23B
Revenue Rankings